Guardian Pharmacy Services, Inc.
GRDN Healthcare Medical Care Facilities
Guardian Pharmacy Services, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 17.9% from fiscal 2024.
- Revenue
- −1.68%
- EPS
- +133.3%
- Free cash flow
- +88.9%
Quarter to September 2026, against a year earlier
Follow GRDN
Alert me
Guardian Pharmacy Services, Inc. (GRDN) Debt to equity
Guardian Pharmacy Services, Inc.'s debt to equity at the end of the quarter to 30 September 2026 was 0.0×, down 0.0× from fiscal 2025 (0.0×). That is below the Medical Care Facilities industry median of 0.4× and in line with the Healthcare sector median of 0.0×.
Debt to equity, annual
Embed this chart
Annual newest first
| Period | Debt to equity | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
| FY2023 | 0.5× | — |
Quarterly newest first
| Period | Debt to equity | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 8 more quarters | Free account |
Debt to equity against peers
| Company | Debt to equity |
|---|---|
| BKD Brookdale Senior Living Inc. compare | −156× |
| GRDN Guardian Pharmacy Services, Inc. | 0.0× |
| ADUS Addus HomeCare Corporation compare | 0.0× |
| NHC National HealthCare Corporation compare | 0.0× |
| MD Pediatrix Medical Group, Inc. compare | 0.7× |
| ASTH Astrana Health, Inc. compare | 1.1× |
| ACHC Acadia Healthcare Company, Inc. compare | 1.2× |
| SGRY Surgery Partners, Inc. compare | 1.2× |
| AVAH Aveanna Healthcare Holdings Inc. compare | 5.1× |
| Medical Care Facilities industry median | 0.4× |
| Healthcare sector median | 0.0× |
| Market median | 0.1× |
What Debt to equity is
Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.
(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)
More on GRDN
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on invested capital
- Current ratio
- Shares outstanding
- Book value per share
- The full statement